Full name
BIOMANTIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
01.49.Z - Crop and animal production, hunting and related service activities
46.23.Z - Wholesale trade of live animals
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 51,6 | 0,9 | -4,7 | -595,2 |
EBITDA | 53,7 | 2,4 | -4,5 | -289,1 |
Short time liabilities | 21,7 | 37,3 | 48,8 | 30,8 |
Equity capital | -34,9 | -34 | -38,6 | -13,8 |
Operating profit (EBIT) | 53,7 | 2,4 | -4,5 | -289,1 |
Assets | 253,7 | 253,4 | 236,2 | -6,8 |
Net profit (loss) | 51,6 | 0,9 | -4,7 | -595,2 |
Cash | 16,5 | 15,7 | 1,7 | -88,9 |
Net income from sale | 196,9 | 197,9 | 198,5 | 0,3 |
Liabilities and provisions for liabilities | 288,6 | 287,3 | 274,8 | -4,4 |
Working assets | 41,5 | 41,2 | 24 | -41,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -147,9 | -2,8 | 12,1 | 14,9 |
Equity capital to total assets | -13,8 | -13,4 | -16,4 | -3 |
Gross profit margin | 26,2 | 0,5 | -2,4 | -2,9 |
EBITDA Margin | 27,3 | 1,2 | -2,3 | -3,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 40 | 69 | 90 | 21 |
Current financial liquidity indicator | 1.808395266532898 | 1.0461599826812744 | 0.4474114179611206 | -0,6 |
Net dept to EBITDA | 4.715410232543945 | 99.52677154541016 | -50.00125503540039 | -149,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane